We are live on
!
Find out more
Neuberger Berman Group Portfolio holdings
AUM
$150B
1-Year Est. Return
40.08%
This Fund
S&P 500
This Quarter
Est. Return
+12.24%
1 Year Est. Return
+40.08%
3 Year Est. Return
+113.08%
5 Year Est. Return
+141.06%
10 Year Est. Return
+565.4%
AUM
$130B
AUM Growth
+$10.6B
(+8.8%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
21.27%
Holding
2,138
New
167
Increased
1,007
Reduced
798
Closed
89
Avg Time Held Equity + Options
21.9
quarters
Top 10 Avg Time Held Equity + Options
22.3
quarters
Top 20 Avg Time Held Equity + Options
17.6
quarters
Avg Time Held Equity only
21.9
quarters
Top 10 Avg Time Held Equity only
22.3
quarters
Top 20 Avg Time Held Equity only
17.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$338M |
| 2 |
Meta Platforms (Facebook)
META
|
+$297M |
| 3 |
Boeing
BA
|
+$208M |
| 4 |
UnitedHealth
UNH
|
+$183M |
| 5 |
Linde
LIN
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kroger
KR
|
+$306M |
| 2 |
Accenture
ACN
|
+$268M |
| 3 |
Goldman Sachs
GS
|
+$191M |
| 4 |
Palantir
PLTR
|
+$169M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.98% |
| 2 | Financials | 14.56% |
| 3 | Industrials | 11.84% |
| 4 | Consumer Discretionary | 9.48% |
| 5 | Healthcare | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2026
T1 Energy
TE
$998M
| $14.7K | ﹤0.01% |
11,945
| – | – |
2024 Q4
2 quarters
|
|
2027
GrafTech
EAF
$238M
| $14.6K | ﹤0.01% |
1,502
+74
| +5% | +$654 |
2025 Q1
1 quarter
|
|
2028
DELISTED
Esperion Therapeutics
ESPR
| $14K | ﹤0.01% |
14,250
+1,894
| +15% | +$1.9K |
2024 Q3
3 quarters
|
|
2029
Enlivex Ltd
ENLV
$5.06M
| $12.3K | ﹤0.01% |
733
-200
| -21% | -$2.97K |
2025 Q1
1 quarter
|
|
2030
Atossa Therapeutics
ATOS
$24.3M
| $12.2K | ﹤0.01% |
980
| – | – |
2024 Q3
3 quarters
|
|
2031
i-80 Gold Corp
IAUX
$1.38B
| $11.8K | ﹤0.01% |
19,718
-4,472
| -18% | -$2.64K |
2024 Q3
3 quarters
|
|
2032
Blink Charging
BLNK
$67.4M
| $11.7K | ﹤0.01% |
12,399
| – | – |
2024 Q4
2 quarters
|
|
2033
Purple Innovation
PRPL
$8.15M
| $11.4K | ﹤0.01% |
626
| – | – |
2025 Q1
1 quarter
|
|
2034
OneMedNet
ONMD
$25M
| $11.1K | ﹤0.01% |
1,950
| – | – |
2024 Q2
4 quarters
|
|
2035
BARK
BARK
$72.4M
| $10.5K | ﹤0.01% |
+596
| New | +$13.7K |
2025 Q2
0 quarters
|
|
2036
Ocugen
OCGN
$324M
| $10.4K | ﹤0.01% |
+10,744
| New | +$8.91K |
2025 Q2
0 quarters
|
|
2037
LanzaTech
LNZA
$80.2M
| $8.72K | ﹤0.01% |
322
+26
| +9% | +$638 |
2024 Q4
2 quarters
|
|
2038
DELISTED
ARKO Corp Warrant
ARKOW
| $2.63K | ﹤0.01% |
206,760
-114,760
| -36% | -$2.4K |
2021 Q4
14 quarters
|
|
2039
Silexion Therapeutics Warrant
SLXNW
$30.9K
| $1.29K | ﹤0.01% |
31,552
| – | – |
2024 Q3
3 quarters
|
|
2040
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
| $341 | ﹤0.01% |
32,468
| – | – |
2024 Q2
4 quarters
|
|
2041
Advance Auto Parts
AAP
$2.55B
| – | – |
-5,140
| Closed | -$202K | – |
|
2042
Absci
ABSI
$1.74B
| – | – |
-10,529
| Closed | -$26.4K | – |
|
2043
Agilon Health
AGL
$1.38B
| – | – |
-426
| Closed | -$46.1K | – |
|
2044
Allogene Therapeutics
ALLO
$504M
| – | – |
-16,621
| Closed | -$24.3K | – |
|
2045
Amarin Corp
AMRN
$254M
| – | – |
-1,438
| Closed | -$12.9K | – |
|
2046
Autohome
ATHM
$2.38B
| – | – |
-11,424
| Closed | -$317K | – |
|
2047
Astronics
ATRO
$2.76B
| – | – |
-30,000
| Closed | -$604K | – |
|
2048
DELISTED
The AZEK Co
AZEK
| – | – |
-458,712
| Closed | -$22.4M | – |
|
2049
CALL
BioMarin Pharmaceuticals
BMRN
$10.6B
| – | – |
-2,899
| Closed | -$957K | – |
|
2050
DELISTED
Brookline Bancorp
BRKL
| – | – |
-11,969
| Closed | -$130K | – |
|
Similar funds
Neuberger Berman Group's Q2 2025 Portfolio in Review
As of Q2 2025, Neuberger Berman Group held 2,138 positions worth $130B, up 8.8% from $119B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Neuberger Berman Group's Q2 2025 filing shows 167 new, 1,007 increased, 798 reduced and 89 closed positions. Its largest new stake was Caris Life Sciences: 6,239,520 shares worth $167M. The largest sale was Kroger, an estimated $306M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Neuberger Berman Group's largest Q2 2025 buy was Caris Life Sciences: 6,239,520 shares worth $167M.
- Neuberger Berman Group added most to Home Depot in Q2 2025, an estimated $338M increase.
- Neuberger Berman Group's biggest Q2 2025 reduction was Kroger, cutting an estimated $306M.
- Neuberger Berman Group fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2025, selling an estimated $73.6M.
- Neuberger Berman Group's ten largest holdings make up 21% of its $130B portfolio in Q2 2025.
- Neuberger Berman Group opened 167 new positions and closed 89 in Q2 2025.
- Neuberger Berman Group's portfolio value rose 8.8% quarter-over-quarter to $130B.
Based on Neuberger Berman Group's 13F filing for Q2 2025, filed 13 Aug 2025.